|
| |||||||||||||
CHIL 2027 : AHLI Conference on Health, Inference, and Learning | |||||||||||||
| Link: https://chil.ahli.cc/submit/call-for-papers/ | |||||||||||||
| |||||||||||||
Call For Papers | |||||||||||||
|
The AHLI Conference on Health, Inference, and Learning (CHIL) solicits work across a variety of disciplines at the intersection of machine learning and health. CHIL 2027 invites submissions focused on artificial intelligence and machine learning (AI/ML) techniques that address opportunities and challenges in health, which we view broadly as including clinical healthcare, public health, population health, and beyond.
Topics of Interest CHIL invites submissions on a broad range of topics at the intersection of machine learning and health, including but not limited to: Technical contributions: modeling, inference, and estimation in health-focused or health-inspired settings. Applied and evaluative research: applying, characterizing, auditing, evaluating, and benchmarking ML approaches to healthcare problems. Societal impacts: effects of health AI on clinical practice, patient experience, access, costs, and equity, responsible design, implementation, and oversight. Submission Format and Guidelines Submission Site Submissions should be made via OpenReview (conference submission link to follow). All authors must have an OpenReview account with a complete profile to support conflict-of-interest checks. Account approval can take up to two weeks, so please register by January 15 to ensure you can submit by the February 3 deadline. Length and Formatting Submitted papers must be 8-10 pages (including all figures and tables); an Overleaf template is available here. Unlimited additional pages can be used for references and additional supplementary materials (e.g. appendices). Reviewers will not be required to read the supplementary materials. Double Blind Peer Review Policy The review process is mutually anonymous (aka “double blind”). Your submitted paper, as well as any supporting text or revisions provided during the discussion period, should be completely anonymized (including links to code repositories). Please do not include any identifying information, and refrain from citing the authors’ own prior work in anything other than third-person. Violations of this anonymity policy at any stage before final manuscript acceptance decisions may result in rejection without further review. Conference organizers and reviewers are required to maintain confidentiality of submitted material. Upon acceptance, the titles, authorship, and abstracts of papers will be released prior to the conference. Required Sections Three sections will be required at the end of the manuscript and will not count toward page limits: 1) Data and Code Availability, 2) Institutional Review Board (IRB), 3) Statement on AI Use. If any of the sections are missing or not anonymized, the conference organizers reserve the right to desk-reject the submission. Data and Code Availability: This section should include: What data you use (including citations if appropriate) and whether the data are or will be made available to other researchers. If it is private data, you should describe the data vaguely and without citation, e.g. reference as “data from an anonymous health system”, to avoid de-anonymization during the review phase. Computer software submissions should include an anonymized code link (e.g. https://anonymous.4open.science/) or code attached as supplementary material, licensing information, and provide documentation to facilitate use and reproducibility (e.g., package versions, README, intended use, and execution examples that facilitate execution by other researchers). If you are not sharing code at the time of submission, you must explicitly state that you are not making your code available. Institutional Review Board (IRB): This initial section is required. You should list one of the below, alongside a one-sentence explanation of why your research falls into that category: “The research does not require IRB approval” “This research has been designated by our IRB as Not Human Subject Research” “This research has been approved by our IRB, and we will add the IRB institution and number upon acceptance.” For guidance on whether IRB approval is required, please consult your local Institutional Review Board (or equivalent ethics committee). In the U.S., authors may find the Office for Human Research Protections (OHRP) decision charts helpful: https://www.hhs.gov/ohrp/regulations-and-policy/decision-charts-2018/. Statement on AI Usage: All submissions must include a Statement on AI Use, which does not count toward the page limit. This statement should disclose any use of AI tools in experimentation, analysis, or manuscript preparation. Spell checkers and grammar suggestions do not need to be disclosed. For each use, state the tool and version, the task, and how the authors verified the output. If no AI tools were used, state “None.” We recommend following the format of the ICLR 2027 AI Policy for Authors. |
|